Technical Analysis for SPRY - ARS Pharmaceuticals, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
B | 8.26 | -2.82% | -0.24 |
SPRY closed down 2.82 percent on Wednesday, April 24, 2024, on 43 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: May 13
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
NR7 | Range Contraction | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
50 DMA Resistance | Bearish | -2.82% | |
Stochastic Buy Signal | Bullish | -2.82% | |
Lower Bollinger Band Walk | Weakness | -2.82% | |
Gapped Up | Strength | -2.82% | |
Oversold Stochastic | Weakness | -2.82% | |
MACD Bearish Centerline Cross | Bearish | 0.61% | |
Lower Bollinger Band Walk | Weakness | 0.61% | |
Below Lower BB | Weakness | 0.61% |
Alert | Time |
---|---|
Possible NR7 | about 16 hours ago |
Lower Bollinger Band Support | about 17 hours ago |
Down 3% | about 19 hours ago |
60 Minute Opening Range Breakdown | about 19 hours ago |
Fell Below Previous Day's Low | about 19 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/13/2024
ARS Pharmaceuticals, Inc. develops ARS-1, a novel intranasal epinephrine spray with absorption technology for patients and their families at-risk of severe allergic reactions to food, medications, and insect bites. Its product includes Neffy, a low-dose intranasal epinephrine nasal spray. The company was incorporated in 2015 and is based in San Diego, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Allergy Respiratory Therapy Respiratory Diseases Type I Hypersensitivity Allergology Nasal Administration Anaphylaxis
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Allergy Respiratory Therapy Respiratory Diseases Type I Hypersensitivity Allergology Nasal Administration Anaphylaxis
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 11.27 |
52 Week Low | 2.55 |
Average Volume | 783,273 |
200-Day Moving Average | 6.38 |
50-Day Moving Average | 8.76 |
20-Day Moving Average | 9.19 |
10-Day Moving Average | 8.76 |
Average True Range | 0.51 |
RSI (14) | 40.48 |
ADX | 23.62 |
+DI | 20.07 |
-DI | 24.26 |
Chandelier Exit (Long, 3 ATRs) | 9.75 |
Chandelier Exit (Short, 3 ATRs) | 9.66 |
Upper Bollinger Bands | 10.32 |
Lower Bollinger Band | 8.07 |
Percent B (%b) | 0.09 |
BandWidth | 24.55 |
MACD Line | -0.12 |
MACD Signal Line | 0.06 |
MACD Histogram | -0.1768 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 8.85 | ||||
Resistance 3 (R3) | 8.88 | 8.71 | 8.75 | ||
Resistance 2 (R2) | 8.71 | 8.56 | 8.70 | 8.71 | |
Resistance 1 (R1) | 8.49 | 8.47 | 8.40 | 8.46 | 8.68 |
Pivot Point | 8.32 | 8.32 | 8.28 | 8.31 | 8.32 |
Support 1 (S1) | 8.10 | 8.17 | 8.01 | 8.07 | 7.84 |
Support 2 (S2) | 7.93 | 8.08 | 7.92 | 7.81 | |
Support 3 (S3) | 7.71 | 7.93 | 7.77 | ||
Support 4 (S4) | 7.68 |